PRGO - PERRIGO Co plc


11.39
-0.950   -8.341%

Share volume: 6,056,597
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%

$12.34
-0.95
-0.08%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-30-2024 06-29-2024 09-28-2024 12-31-2024 03-29-2025 06-28-2025 09-27-2025 12-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Report Date 05-07-2024 08-02-2024 11-06-2024 02-28-2025 05-07-2025 08-06-2025 11-05-2025 02-26-2026
Total revenue 1.082 B 1.066 B 1.088 B 1.138 B 1.044 B 1.056 B 1.043 B 1.110 B
Cost of revenue 724.400 M 670.800 M 683.100 M 752.400 M 651.600 M 693.400 M 666.200 M 747.400 M
Gross profit 357.700 M 394.700 M 404.400 M 385.900 M 392.300 M 362.900 M 377.100 M 362.200 M
    10.34% 2.46% -4.57% 1.66% -7.49% 3.91% -3.95%  
Operating expenses 159.400 M 155.500 M 142.900 M 122.400 M 138.900 M 135.000 M 119.100 M 138.300 M
Selling general and admin 130.400 M 126.100 M 116.900 M 94.600 M 112.200 M 113.000 M 94.200 M 116.500 M
Research and development 29.000 M 29.400 M 26.000 M 27.800 M 26.700 M 22.000 M 24.900 M 21.800 M
Total expenses 412.900 M 421.200 M 324.000 M 271.700 M 345.400 M 317.500 M 304.500 M 1.649 B
    2.01% -23.08% -16.14% 27.13% -8.08% -4.09% 441.64%  
Operating income -55.200 M -26.500 M 80.400 M 114.200 M 46.900 M 45.400 M 72.600 M -1.287 B
Ebit -55.600 M -29.900 M 84.500 M 114.800 M 47.300 M 42.800 M 63.000 M -1.289 B
Pretax income -98.600 M -74.000 M 21.800 M 70.100 M 8.300 M 3.200 M 22.400 M -1.332 B
    -24.95% -129.46% 221.56% -88.16% -61.45% 600.00% -6,045.54%  
Income tax -102.700 M 31.700 M 39.400 M 111.600 M 8.200 M 3.700 M 9.700 M 82.800 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                   
Net income 2.000 M -108.400 M -21.000 M -44.400 M -6.400 M -8.400 M 7.500 M -1.418 B
    -5,520.00% 80.63% -111.43% 85.59% -31.25% 189.29% -19,008.00%